Predicting chemotherapy-induced thrombocytopenia in cancer patients with solid tumors or lymphoma.

Razzaghdoust, Abolfazl; Mofid, Bahram; Zangeneh, Masoumeh

Razzaghdoust, Abolfazl; Mofid, Bahram; Zangeneh, Masoumeh.

Afiliación

Razzaghdoust A; Student Research Committee, Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mofid B; Department of Oncology, Shohada-e-Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zangeneh M; Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

J Oncol Pharm Pract ; 26(3): 587-594, 2020 Apr.

Article en En | MEDLINE | ID: mdl-31315547

Asunto(s)

Antineoplásicos/efectos adversos; Linfoma/tratamiento farmacológico; Neoplasias/tratamiento farmacológico; Trombocitopenia/inducido químicamente; Antineoplásicos/administración & dosificación; Estudios de Cohortes; Femenino; Humanos; Masculino; Persona de Mediana Edad; Recuento de Plaquetas; Estudios Prospectivos

Palabras clave

Cancer; chemotherapy; predictive factors; thrombocytopenia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trombocitopenia / Linfoma / Neoplasias / Antineoplásicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2020 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google